Charles Leland Rogers MD FACR, FASTRO
Central Nervous System Cancer
Physician
Join to View Full Profile
350 W Thomas RdPhoenix, AZ 85013
Phone+1 602-406-6761
Fax+1 602-406-5515
Dr. Rogers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Charles Rogers is a radiation oncologist in Phoenix, AZ. He received his medical degree from University of Kentucky College of Medicine and has been in practice 31 years. He specializes in central nervous system cancer, treatment of benign disease with radiotherapy, and brachytherapy.
Education & Training
University of North Carolina HospitalsResidency, Radiation Oncology, 1988 - 1991
University of Arizona College of Medicine-PhoenixInternship, Internal Medicine, 1986 - 1987
University of Kentucky College of MedicineClass of 1986
Certifications & Licensure
FL State Medical License 1992 - Present
UT State Medical License 1987 - 2028
AZ State Medical License 1991 - 2027
VA State Medical License 2014 - 2018
NC State Medical License 1988 - 1991
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification ONCOCHART, Bogardus Medical Systems, Inc., 2013-2014
Clinical Trials
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma Start of enrollment: 2009 Jun 01
- Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery Start of enrollment: 2017 Sep 12
Publications & Presentations
PubMed
- Radiation Therapy for Non-Malignant Central Nervous System Tumors, Disorders, and Illnesses - Current Applications and Future Directions.Felix Ehret, Charles Leland Rogers, James Fontanesi, George D Wilson, Bhargava S Chitti
Seminars in Radiation Oncology. 2026-01-01 - 5 citationsBenchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design.Rupesh Kotecha, Eyub Y Akdemir, Tugce Kutuk, Can Ilgın, Manmeet S Ahluwalia
Neuro-Oncology. 2025-09-08 - 34 citationsMolecular classification to refine surgical and radiotherapeutic decision-making in meningioma.Justin Z Wang, Vikas Patil, Alexander P Landry, Chloe Gui, Andrew Ajisebutu
Nature Medicine. 2024-11-01
Journal Articles
- Could low dose thoracic radiation be a treatment for COVID-19 patients to prevent respiratory failure?Wilson GD, Mehta MP, Welsh JS, Chakravarti A, Rogers CL, Fontanesi J, Radiation Research, 2020
- Phase II study of a temozolomide-based chemo-radiotherapy regimen for high-risk low-grade gliomas: Long-term results of Radiation Therapy Oncology Group (RTOG) 0424Fisher BJ, Pugh SL, MacDonald DR, Chakravarti A, Lesser GJ, Fox S, Rogers CL, Werner-Wasik M, Doyle T, Bahary JP, Fiveash JB, Bovi JA, Howard SP, Michael Yu HH, D’Souz..., . International Journal of Radiation Oncology Biology Physics, 2020
- High-risk meningioma: Initial outcomes from NRG Oncology/ RTOG 0539. International Journal of Radiation Oncology Biology PhysicsRogers CL, Won M, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Fogh SE, Youssef E, Deb N, Kwok Y, Robinson CG, Shu HK, Fisher BJ, Panet-Raymond V, M..., International Journal of Radiation Oncology Biology Physics, 2020
Books/Book Chapters
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
